| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Veratric Acid Impurity 5 |
3-AMINO-4-HYDROXY-1,8-NAPHTHALIC ANHYDRIDE |
134870-46-5 |
詳細(xì)
|
| Hexanal Impurity 4 |
N-(4-methoxy-7-methylbenzo[d]thiazol-2-yl)-4-(pyrrolidin-1-ylsulfonyl)benzohydrazide |
851987-78-5 |
詳細(xì)
|
| Veratric Acid Impurity 2 |
(Z)-4-(2-(氨基甲基)-3-氟烯丙氧基)-N-叔丁基苯甲酰胺鹽酸鹽 |
1478364-22-5 |
詳細(xì)
|
| Hexanal Impurity 5 |
艾塞那肽 |
133514-43-9 |
詳細(xì)
|
| Ticagrelor Impurity 227 |
恩夫韋地 |
159519-65-0 |
詳細(xì)
|
| Sitagliptin Impurity 158 |
4-苯甲氧基苯乙酮 |
54696-05-8 |
詳細(xì)
|
| Cibenzoline Impurity 4 |
5-[acetyl-(1,1,2,3,3-pentadeuterio-2,3-dihydroxypropyl)amino]-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide |
928623-33-0 |
詳細(xì)
|
| Torasemide Impurity 32 |
L-苯甘氨酸 |
2935-35-5 |
詳細(xì)
|
| Ertapenem Impurity 41 |
2-甲基-3,4-戊二烯酸乙酯 |
60523-21-9 |
詳細(xì)
|
| Brassicasterol Impurity 5 |
1,4-Bis(3-morpholinopropoxy)benzene |
101956-13-2 |
詳細(xì)
|
| Pramipexole Impurity 63 |
N-(4-硝基苯乙基)乙酰胺 |
6270-07-1 |
詳細(xì)
|
| Hoveyda-Grubbs Catalyst 1st Generation |
1-庚烷磺酸鈉 |
22767-50-6 |
詳細(xì)
|
| Cibenzoline Impurity 1 |
50MG/4000 |
1417905-41-9 |
詳細(xì)
|
| Veratric Acid Impurity 4 |
Dihydro-4,4,5,5-tetramethyl-2(3H)-furanone |
16466-24-3 |
詳細(xì)
|
| Veratric Acid Impurity 7 |
6-CHLOROISOXAZOLO[5,4-B]PYRIDIN-3-AMINE |
1502034-41-4 |
詳細(xì)
|
| Hexanal Impurity 3 |
5-甲氧基-3-甲基-1H-吡唑 |
3201-22-7 |
詳細(xì)
|
| Veratric Acid Impurity 1 |
2,1,3-苯并噻二唑-5-甲醛 |
71605-72-6 |
詳細(xì)
|
| Resorcinol Impurity 6 |
Exendin-4 (1-8) |
1802078-29-0 |
詳細(xì)
|
| Grubbs Catalyst, 2nd Generation |
4-羥基-4-((甲基氨基)甲基)哌啶-1-甲酸叔丁酯 |
1073559-55-3 |
詳細(xì)
|
| Dabigatran Impurity 126 |
4‘-芐氧基苯丙酮 |
4495-66-3 |
詳細(xì)
|
| Zanubrutinib Impurity 13 |
醋酸奈西立肽 |
114471-18-0 |
詳細(xì)
|
| Mefenamic Acid Impurity 11 |
(S)-(+)-2-苯基甘氨酸甲酯 |
15028-39-4 |
詳細(xì)
|
| Faropenem Impurity 37 |
2,3-丁二烯酸甲酯 |
18913-35-4 |
詳細(xì)
|
| Brassicasterol Impurity 4 |
4-(3-氯丙基)嗎啉鹽酸鹽 |
57616-74-7 |
詳細(xì)
|
| Fasudil Impurity 57 |
對(duì)羥基苯甲酸異戊酯 |
6521-30-8 |
詳細(xì)
|
| Cibenzoline Impurity 3 |
哌嗪-D8 二鹽酸鹽 |
314062-45-8 |
詳細(xì)
|
| *Hexanal Impurity 2 |
化合物 BD 1008 FREE BASE |
138356-08-8 |
詳細(xì)
|
| Veratric Acid Impurity 3 |
10H-吩噻嗪-3-羧酸 |
68230-59-1 |
詳細(xì)
|
| Veratric Acid Impurity 6 |
2-氟-3-羥基異煙酸 |
1227576-95-5 |
詳細(xì)
|
| Veratric Acid |
2-甲氧基-5-硝基苯-1,4-二胺 |
25917-90-2 |
詳細(xì)
|
| Tolperisone Impurity 8 |
艾塞那肽 |
141758-74-9 |
詳細(xì)
|
| Grubbs Catalyst, 1st Generation |
大豆肽 |
107761-42-2 |
詳細(xì)
|
| Paracetamol Impurity 25 |
3-芐氧基苯乙酮 |
34068-01-4 |
詳細(xì)
|
| Dithranol Impurity 11 |
醋酸普蘭林肽 |
196078-30-5 |
詳細(xì)
|
| Tofacitinib Impurity 230 |
3,6-二氯-1,2-苯二硫醇 |
87314-49-6 |
詳細(xì)
|
| Faropenem Impurity 36 |
2,3-丁二酸乙酯 |
14369-81-4 |
詳細(xì)
|
| 1-(5-methoxy-2-methylphenyl)thiourea |
對(duì)氰基苯乙胺 |
132224-93-2 |
詳細(xì)
|
| Dapoxetine Impurity 94 |
福爾可定EP雜質(zhì)D |
291532-18-8 |
詳細(xì)
|
| Brassicasterol Impurity 6 |
4-[3-(4-Morpholinyl)propoxy]-phenol |
93759-97-8 |
詳細(xì)
|
| Cibenzoline Impurity 2 |
|
1899833-85-2 |
詳細(xì)
|
| FiMasartan Impurity 28 |
C-132,3,7,8-TCDD |
76523-40-5 |
詳細(xì)
|
| Triclosan Impurity 11 |
莫能菌素 |
17090-79-8 |
詳細(xì)
|
| Pramoxine Impurity 5 |
Boc-L-纈氨酸 |
13734-41-3 |
詳細(xì)
|
| *Pholcodine Impurity 1 (Pholcodine EP Impurity A) |
|
266360-74-1 |
詳細(xì)
|
| Anthraquinone Impurity 9 |
4-氨基-2-硝基吡啶 |
14916-64-4 |
詳細(xì)
|
| Cefaclor Impurity 38 |
|
1027285-74-0 |
詳細(xì)
|
| Dopamine Impurity 45 |
|
57793-81-4 |
詳細(xì)
|
| Mirabegron Impurity 58 |
3,4-二氨基吡啶1-氧化物 |
927814-75-3 |
詳細(xì)
|
| TAK438 Impurity 139 |
氟考酮新戊酸酯EP雜質(zhì)C |
79884-56-3 |
詳細(xì)
|
| Metamfepramone Impurity 3 |
對(duì)異丙基溴芐 |
73789-86-3 |
詳細(xì)
|
| Verapamil Impurity 29 |
2-硝基苯基丙酮酸 |
5461-32-5 |
詳細(xì)
|
| Cyclohexane Impurity 3 |
α-甲基-4-硝基苯乙酸 |
19910-33-9 |
詳細(xì)
|
| Lenvatinib Impurity 10 |
7H-Purine-7-acetic acid, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-, ethyl ester |
7029-96-1 |
詳細(xì)
|
| Levetiracetam Impurity 59 |
2-噻吩乙酸 |
1918-77-0 |
詳細(xì)
|
| Tetracaine Impurity 12 |
|
1197-42-8 |
詳細(xì)
|
| Methylparaben Impurity 9 |
4-異丙氧基吡啶 |
53708-19-3 |
詳細(xì)
|
| Mirabegron Impurity 43 |
4-氨基吡啶氧化物 |
3535-75-9 |
詳細(xì)
|
| Cefaclor Impurity 37 |
(4S,2RS)-2-甲基噻唑-4-羧酸 |
205985-91-7 |
詳細(xì)
|
| Ethyl Acetate Impurity 5 |
4,5-二氟鄰苯二甲酸 |
18959-31-4 |
詳細(xì)
|
| Pholcodine Monohydrate |
磷酸氟達(dá)拉濱雜質(zhì)B |
149297-79-0 |
詳細(xì)
|
| Dexrazoxane Impurity 21 |
5-羥甲基噻唑 |
38585-74-9 |
詳細(xì)
|
| Umbelliferone Impurity 2 |
L-丙氨酸-13C3 |
100108-77-8 |
詳細(xì)
|
| tert-Butyl 4-hydroxy-4-[(methylamino)-methyl]piperidine-1-carboxylate |
間羥基-2-羰基丙酸 |
4607-41-4 |
詳細(xì)
|
| Phenolphthalein Impurity 1 |
氯仿酸新戊酯 |
20412-38-8 |
詳細(xì)
|
| Cyclohexane Impurity 2 |
PHOLCODINE-N,N'-DIOXIDE |
433308-91-9 |
詳細(xì)
|
| Chlorzoxazone Impurity 23 |
Doxofylline Impurity 7 |
43135-57-5 |
詳細(xì)
|
| Bufexamac Impurity 5 |
|
|
詳細(xì)
|
| Tributyl Phosphate Impurity 10 |
2-氯-1-甲基吡啶碘化物 |
14338-32-0 |
詳細(xì)
|
| Ioversol Impurity 19 |
(R)-2-溴丙酸甲酯 |
20047-41-0 |
詳細(xì)
|
| Pramoxine Impurity 3 |
|
14286-03-4 |
詳細(xì)
|
| Taurodeoxycholic Acid Impurity 5 |
金葉樹(shù)苷癸酯 |
164066-23-3 |
詳細(xì)
|
| Terbutaline Impurity 65 |
1-氯-3,5-二對(duì)氯苯甲酰氧基-2-脫氧-D-核糖 |
3601-90-9 |
詳細(xì)
|
| Anthraquinone Impurity 10 |
4-氨基-3,5-二硝基吡啶 |
31793-29-0 |
詳細(xì)
|
| Phloroglucinol Impurity 61 |
(對(duì)硝基苯基)丙酮酸 |
38335-24-9 |
詳細(xì)
|
| Ethyl Acetate(Acetidin) |
2-甲基-4,5-二氫噻唑-4-羧酸 |
84184-18-9 |
詳細(xì)
|
| Levocarnitine Impurity 44 |
Fludarabine EP impurity G |
548774-56-7 |
詳細(xì)
|
| Pramlintide Acetate |
|
67478-04-0 |
詳細(xì)
|
| 1-methyl-3-(2-Cyclopentane) |
2-(3-羥基苯基)乙醇 |
13398-94-2 |
詳細(xì)
|
| Vortioxetine Impurity 58 |
Doxofylline Impurity 11 |
109403-76-1 |
詳細(xì)
|
| Nicotinic Acid Impurity 23 |
多索茶堿雜質(zhì)12 |
1429636-72-5 |
詳細(xì)
|
| Esomeprazole Impurity 138 |
4-(N-甲基-N-羥乙基)氨基苯甲醛 |
1201-91-8 |
詳細(xì)
|
| Simethicone Impurity 7 |
(2R,3R)-二乙基-2,3-環(huán)氧琥珀酸 |
74243-85-9 |
詳細(xì)
|
| Benzoyl Peroxide Impurity 10 |
甲基潑尼松 |
1247-42-3 |
詳細(xì)
|
| Pramoxine Impurity 8 |
(S)-4-異丙基惡唑-2,5-二酮 |
24601-74-9 |
詳細(xì)
|
| *Pholcodine Impurity 2 (Pholcodine EP Impurity B) |
4-(PIPERAZIN-1-YLMETHYL)BENZOIC ACID |
220213-15-0 |
詳細(xì)
|
| Palbociclib Impurity 139 |
莫恩菌素 C |
31980-87-7 |
詳細(xì)
|
| Thiazolidine Impurity 1 |
頭孢布烯側(cè)鏈 |
115065-79-7 |
詳細(xì)
|
| Dexpanthenol Impurity 8 |
|
2724765-58-4 |
詳細(xì)
|
| Nicotinic Acid Impurity 24 |
魯苯達(dá)唑 |
90509-02-7 |
詳細(xì)
|
| Phenylpyruvic Acid |
甲基莫能菌素酯 |
28636-21-7 |
詳細(xì)
|
| Fampridine Impurity 19 |
雙酚M |
13595-25-0 |
詳細(xì)
|
| Phenylpyruvic Acid Impurity 2 |
Monensin benzyl ester |
127648-49-1 |
詳細(xì)
|
| Dexpanthenol Impurity 7 |
|
2720504-58-3 |
詳細(xì)
|
| Decitabine Impurity 37 |
4-PREGNENE-3,20-DIONE 3-[O-CARBOXYMETHYL]OXIME |
50909-89-2 |
詳細(xì)
|
| Fampridine Impurity 17 |
磺基琥珀酸 |
5138-18-1 |
詳細(xì)
|
| Fampridine Impurity 1（Fampridine N-Oxide HCl） |
鄰苯二甲酸單乙基己基酯 |
4376-20-9 |
詳細(xì)
|
| Phenylpyruvic Acid Impurity 1 |
|
119421-96-4 |
詳細(xì)
|
| Thiazolidine Impurity 2 |
頭孢布烯母核 |
36923-21-4 |
詳細(xì)
|
| Bromfenac Impurity 53 |
睪酮3-CMO |
10190-93-9 |
詳細(xì)
|
| Nicotinic Acid Impurity 25 |
魯苯達(dá)唑-D3 |
1448346-27-7 |
詳細(xì)
|